Growth Metrics

AtriCure (ATRC) Change in Accured Expenses (2016 - 2025)

AtriCure (ATRC) has disclosed Change in Accured Expenses for 16 consecutive years, with $3.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 37.85% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.0 million, a 483.57% increase, with the full-year FY2025 number at $7.0 million, up 483.57% from a year prior.
  • Change in Accured Expenses was $3.7 million for Q4 2025 at AtriCure, down from $9.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $9.1 million in Q3 2025 to a low of -$14.9 million in Q1 2024.
  • A 5-year average of $1.3 million and a median of $3.2 million in 2021 define the central range for Change in Accured Expenses.
  • Peak YoY movement for Change in Accured Expenses: surged 1022.3% in 2021, then crashed 694.83% in 2022.
  • AtriCure's Change in Accured Expenses stood at $4.3 million in 2021, then plummeted by 61.72% to $1.6 million in 2022, then surged by 341.95% to $7.2 million in 2023, then fell by 17.76% to $6.0 million in 2024, then crashed by 37.85% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Change in Accured Expenses are $3.7 million (Q4 2025), $9.1 million (Q3 2025), and $6.7 million (Q2 2025).